EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   7.4.2.8 | Adenocarcinoma |
20402675 |
CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 7.4.2.8 | Adenocarcinoma |
21470935 |
Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: An association with histopathological parameters. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 7.4.2.8 | Gastritis |
11292705 |
Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models. |
ongoing research
unassigned |
2
0 |
| 7.4.2.8 | Infections |
8206843 |
Genetic complementation analysis of the Agrobacterium tumefaciens virB operon: virB2 through virB11 are essential virulence genes. |
causal interaction
unassigned |
3
0 |
| 7.4.2.8 | Infections |
11557148 |
Heterogeneity of Helicobacter pylori cag genotypes in experimentally infected mice. |
unassigned |
0 |
| 7.4.2.8 | Infections |
11566978 |
Role of Agrobacterium VirB11 ATPase in T-pilus assembly and substrate selection. |
ongoing research
unassigned |
1
0 |
| 7.4.2.8 | Infections |
17340996 |
[Prevalence of pathogenic genes of Campylobacter jejuni isolated from humans in Poland between 2003-2005] |
unassigned |
0 |
| 7.4.2.8 | Infections |
18469100 |
VirB3 to VirB6 and VirB8 to VirB11, but not VirB7, are essential for mediating persistence of Brucella in the reticuloendothelial system. |
therapeutic application
unassigned |
1
0 |
| 7.4.2.8 | Infections |
20106696 |
The relationship between Helicobacter pylori genes cagE and virB11 and gastric cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
4
0 |
| 7.4.2.8 | Infections |
25605762 |
Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS: a chemotherapeutic target for small molecule ATPase inhibitors. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
